Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Pyrimidine Nucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105693627A reveals efficient Ru-pheox catalysis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN108314655A enables high-purity chiral nucleoside synthesis with 99% ee, reducing API manufacturing costs and ensuring reliable supply chain for pharmaceutical intermediates.